With IBM Analytics technologies against cancer and other diseases

12.12.2011 09:51

Cloud-based platform opens up a huge reservoir of information for science and business

New cloud-based analytics software and services from IBM enable quick access to global patent data and thus the largest database for innovation. The Strategic IP Insight Platform (SIIP) brings this information together for the first time and enables its analytical evaluation. This allows companies to use scientific literature, patents and molecular data much more quickly and effectively for their research and development work.

Companies in the healthcare, chemical and consumer goods industries in particular can benefit from SIIP. Their business success often depends on a few unique innovations. In order to identify new market opportunities, you need quick and effective access to existing publications and published patents. In the past, this required lengthy sorting, cataloging and analysis of large amounts of information.

With the help of SIIP, this process can be significantly accelerated. Until recently, for example, chemical data in patents was documented in a form that could not be read by computers. SIIP technology understands and can read these molecular structures illustrated in the form of chemical compounds - unlike other patent search technologies. This allows researchers to access information in the patents almost in real time.

SIIP brings together patent documents from the US Patent and Trademark Office, the European Patent Office and the World Intellectual Property Organization (WIPO), as well as the documents from the publicly available bibliographic database of the US National Center for Biotechnology Information (NCBI).